Medtronic PLC vs Msci Inc — how do they compare? Medtronic PLC trades at $90.48 (market cap $116.07B), while Msci Inc trades at $562 (market cap $40.84B). The key difference: Medtronic PLC is far larger — about 2.8× Msci Inc's market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| MDT | MSCI | |
|---|---|---|
Market Cap | $116.07B | $40.84B |
Sector | Health | Financials |
52-Week High | $105.35 | $643.83 |
52-Week Low | $73.75 | $511.84 |
Enterprise Value | $134.82B | $47.00B |
Dividend Yield | 3.18% | 1.46% |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →